Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

[Influenza point-of-care test in the GP practice and Emergency Department; analytical accuracy and added value].

Verhees RAF, Lutgens SPM, Kusters R, Dinant GJ, Cals JWL.

Ned Tijdschr Geneeskd. 2019 Aug 29;163. pii: D3806. Dutch.

PMID:
31483584
2.

Implementation of point-of-care testing and a temporary influenza ward in a Dutch hospital.

Lankelma JM, Hermans MHA, Hazenberg EHLCM, Macken T, Dautzenberg PLJ, Koeijvoets KCMC, Jaspers JWH, van Gageldonk-Lafeber AB, Lutgens SPM.

Neth J Med. 2019 Apr;77(3):109-115.

3.

Do safety engineered devices reduce needlestick injuries?

Schuurmans J, Lutgens SP, Groen L, Schneeberger PM.

J Hosp Infect. 2018 Sep;100(1):99-104. doi: 10.1016/j.jhin.2018.04.026. Epub 2018 May 5.

PMID:
29738783
4.

Cost of Nosocomial Outbreak Caused by NDM-1-Containing Klebsiella pneumoniae in the Netherlands, October 2015-January 2016.

Mollers M, Lutgens SP, Schoffelen AF, Schneeberger PM, Suijkerbuijk AWM.

Emerg Infect Dis. 2017 Sep;23(9):1574-1576. doi: 10.3201/eid2309.161710.

5.

Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers.

Bosch T, Lutgens SPM, Hermans MHA, Wever PC, Schneeberger PM, Renders NHM, Leenders ACAP, Kluytmans JAJW, Schoffelen A, Notermans D, Witteveen S, Bathoorn E, Schouls LM.

J Clin Microbiol. 2017 Aug;55(8):2380-2390. doi: 10.1128/JCM.00535-17. Epub 2017 May 17.

6.

Listeria Endocarditis: A Diagnostic Challenge.

Valckx WJARM, Lutgens SPM, Haerkens-Arends HE, Barneveld PC, Beutler JJ, Hoogeveen EK.

J Investig Med High Impact Case Rep. 2017 Apr 10;5(2):2324709617698995. doi: 10.1177/2324709617698995. eCollection 2017 Apr-Jun.

7.

Cathepsin K Deficiency Prevents the Aggravated Vascular Remodeling Response to Flow Cessation in ApoE-/- Mice.

Donners MM, Bai L, Lutgens SP, Wijnands E, Johnson J, Schurgers LJ, Liu CL, Daemen MJ, Cleutjens KB, Shi GP, Biessen EA, Heeneman S.

PLoS One. 2016 Sep 16;11(9):e0162595. doi: 10.1371/journal.pone.0162595. eCollection 2016.

8.

[Neurological symptoms with a hepatitis E virus infection].

van de Wardt J, Olde Dubbelink TB, Visée HF, Schneeberger PM, Lutgens SP, van Eijk JJ.

Ned Tijdschr Geneeskd. 2016;160:D107. Dutch.

PMID:
27378260
9.

Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.

Frakking FN, Rottier WC, Dorigo-Zetsma JW, van Hattem JM, van Hees BC, Kluytmans JA, Lutgens SP, Prins JM, Thijsen SF, Verbon A, Vlaminckx BJ, Cohen Stuart JW, Leverstein-van Hall MA, Bonten MJ.

Antimicrob Agents Chemother. 2013 Jul;57(7):3092-9. doi: 10.1128/AAC.01523-12. Epub 2013 Apr 22.

10.

Paediatric sepsis-like illness and human parechovirus.

Vanagt WY, Lutgens SP, van Loo IH, Wolffs PF, van Well GT.

Arch Dis Child. 2012 May;97(5):482-3. doi: 10.1136/archdischild-2011-300517. Epub 2012 Jan 30. No abstract available.

PMID:
22294670
11.

Minocycline inhibits apoptotic cell death in a murine model of partial flap loss.

Dumont EA, Lutgens SP, Reutelingsperger CP, Bos GM, Hofstra L.

J Reconstr Microsurg. 2010 Oct;26(8):523-8. doi: 10.1055/s-0030-1262952. Epub 2010 Jul 20.

PMID:
20648419
12.

Cathepsin K gene disruption does not affect murine aneurysm formation.

Bai L, Beckers L, Wijnands E, Lutgens SP, Herías MV, Saftig P, Daemen MJ, Cleutjens K, Lutgens E, Biessen EA, Heeneman S.

Atherosclerosis. 2010 Mar;209(1):96-103. doi: 10.1016/j.atherosclerosis.2009.09.001. Epub 2009 Sep 6.

PMID:
19775691
13.

To do or not to do: IVF and ICSI in chronic hepatitis B virus carriers.

Lutgens SP, Nelissen EC, van Loo IH, Koek GH, Derhaag JG, Dunselman GA.

Hum Reprod. 2009 Nov;24(11):2676-8. doi: 10.1093/humrep/dep258. Epub 2009 Jul 22.

PMID:
19625309
14.

Cathepsin cysteine proteases in cardiovascular disease.

Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S.

FASEB J. 2007 Oct;21(12):3029-41. Epub 2007 May 23. Review.

PMID:
17522380
15.

Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic.

Lutgens SP, Kisters N, Lutgens E, van Haaften RI, Evelo CT, de Winther MP, Saftig P, Daemen MJ, Heeneman S, Cleutjens KB.

J Pathol. 2006 Nov;210(3):334-43.

PMID:
16972305
16.

Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.

Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der Made I, Daugherty A, Sijbers AM, Fisher A, Long CJ, Saftig P, Black D, Daemen MJ, Cleutjens KB.

Circulation. 2006 Jan 3;113(1):98-107. Epub 2005 Dec 19.

PMID:
16365196

Supplemental Content

Loading ...
Support Center